We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · November 21, 2019

T-DM1 Efficacy in Patients With HER2-Positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab

Clinical Breast Cancer

 

Additional Info

Disclosure statements are available on the authors' profiles:

Clinical Breast Cancer
T-DM1 Efficacy in Patients With HER2-Positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study
Clin. Breast Cancer 2019 Oct 24;[EPub Ahead of Print], B Conte, A Fabi, F Poggio, E Blondeaux, C Dellepiane, A D'Alonzo, G Buono, G Arpino, V Magri, G Naso, D Presti, S Mura, A Fontana, F Cognetti, C Molinelli, S Pastorino, C Bighin, L Miglietta, F Boccardo, M Lambertini, L Del Mastro

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading